ArticleJournal of translational medicine2024

Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.

Chanisa Thonusin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.